Rxivist logo

Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques

By Anthony M. Cadena, Forrest F. Hopkins, Pauline Maiello, Allison F. Carey, Eileen A. Wong, Constance J. Martin, Hannah Priyadarshini Gideon, Robert M. DiFazio, Peter Andersen, Philana Ling Lin, Sarah M Fortune, JoAnne L Flynn

Posted 29 Aug 2018
bioRxiv DOI: 10.1101/403691 (published DOI: 10.1371/journal.ppat.1007305)

For many pathogens, including most targets of effective vaccines, infection elicits an immune response that confers significant protection against reinfection. There has been significant debate as to whether natural M. tuberculosis (Mtb) infection confers protection against reinfection. Here we experimentally assessed the protection conferred by concurrent Mtb nfection in macaques, a robust experimental model of human tuberculosis (TB), using a combination of serial imaging and Mtb challenge strains differentiated by DNA identifiers. Strikingly, ongoing Mtb infection provided complete protection against establishment of secondary infection in over half of the macaques and allowed near sterilizing bacterial control for those in which a secondary infection was established. By contrast, boosted BCG vaccination reduced granuloma inflammation but had no impact on early granuloma bacterial burden. These findings are evidence of highly effective concomitant mycobacterial immunity in the lung, which may inform TB vaccine design and development.

Download data

  • Downloaded 432 times
  • Download rankings, all-time:
    • Site-wide: 85,273
    • In microbiology: 5,706
  • Year to date:
    • Site-wide: 163,921
  • Since beginning of last month:
    • Site-wide: 157,231

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide